| Literature DB >> 34355170 |
Gilbert Georg Klamminger1, Jean-Jacques Gérardy2,3, Finn Jelke1,4, Giulia Mirizzi1,4, Rédouane Slimani5,6, Karoline Klein1,4, Andreas Husch7, Frank Hertel1,4,7, Michel Mittelbronn2,3,5,7, Felix B Kleine-Borgmann1,3,5.
Abstract
BACKGROUND: Although microscopic assessment is still the diagnostic gold standard in pathology, non-light microscopic methods such as new imaging methods and molecular pathology have considerably contributed to more precise diagnostics. As an upcoming method, Raman spectroscopy (RS) offers a "molecular fingerprint" that could be used to differentiate tissue heterogeneity or diagnostic entities. RS has been successfully applied on fresh and frozen tissue, however more aggressively, chemically treated tissue such as formalin-fixed, paraffin-embedded (FFPE) samples are challenging for RS.Entities:
Keywords: FFPE; Raman spectroscopy; glioblastoma; machine learning; pathology
Year: 2021 PMID: 34355170 PMCID: PMC8331050 DOI: 10.1093/noajnl/vdab077
Source DB: PubMed Journal: Neurooncol Adv ISSN: 2632-2498
Figure 1.Correlation of Raman spectroscopy and classic histology. (A) Unstained tissue on a CaF2 slide. (B) Colored tissue (HE) on a glass slide. Histologically distinct tissue areas were defined in HE samples (here: example of the vital tumor zone) and visually correlated on subsequent serial CaF2 slides.
Data Overview
| Sample size: 117 FFPE blocks from 59 glioblastomas | ||
|---|---|---|
| Pathohistological area ( | Measuring points training data set ( | Measuring points external validation data set ( |
| Necrosis | 100 | 29 |
| Peritumoral | 105 | 37 |
| Vital zone | 266 | 33 |
Overview about the number of glioblastomas and measurements carried out in total as well as distribution of the measurements related to the two data sets. The external validation data set contains different tumors to avoid bias.
Figure 2.Raman spectroscopy data of histologically defined areas in GBM. Average spectra of the three histologically defined areas in GBM (vital tissue / peritumoral tissue / necrosis). For a better overview, the CaF2 peak at 321 cm–1 has been subtracted. SPECTRAGRYPH software was used for data analyses.
Figure 3.SVM of training data set after validation. Performance of our classifier after internal 5-fold cross-validation. (A) Number of observations of the established classifier, plotted according to histological area (= true class) and prediction based on the Raman spectra (= predicted class). (B) Corresponding TPR (True Positive Rate) and FNR (False Negative Rate) values. The TPR was for vital zone 81% (FNR 19%), for necrosis 60% (FNR 40%) and for peritumoral zone 54% (FNR 46%).
Figure 4.ROC curve and AUC value of our SVM. The ROC curve (receiver operating characteristics curve) and the AUC value (0.86) are shown here and plotted using the example of the necrosis zone.
Figure 5.Distribution of the classifier predictions. Results for the training data set. The non-transparent turquoise blue area represents the misclassification between necrosis and peritumoral zone. On the one hand, measuring points can be divided into three different groups. On the other hand, the number of incorrect classifications between the peritumoral zone and the necrosis is visualized.
Classifier Results of the Validation Data Set
| Necrosis | Peritumoral zone | Vital zone | |
|---|---|---|---|
| True positive rate (=sensitivity) | 59% (17/29) | 54% (20/37) | 79% (26/33) |
| True negative rate (=specificity) | 94% (66/70) | 94% (58/62) | 58% (38/66) |
| Positive predictive value | 81% (17/21) | 83% (20/24) | 48% (26/54) |
| False discovery rate | 19% (4/21) | 17% (4/24) | 52% (28/54) |
Overview of sensitivity, specificity and positive predictive value when using SVM classifier for the validation cohort (n = 99).